Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Carl Millward"'
Autor:
James L Gulley, Rong Deng, Carl Millward, Jason M Redman, Yao Chiang, Ariel Niedecken, Kacy Stadtmiller, Edward Garmey, Vincent Poon, Michael A Asensio, Janice Lansita, Kyle P Carter, Ellen K Wagner, Erica L Stone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cd7653e4b6fc47cc83ad4632ba2809b7
Autor:
Lixia Wang, John Powderly, Tanios Bekaii-Saab, Susanna Ulahannan, Ngan Nguyen, Deborah Doroshow, Yan Xing, Mark Whidden, Carl Millward, Jonathan Benjamin, S John Weroha, Frances Valdes-Albini, Kimberly Walter, Andrew Wrong, Paul Del Castillo, Steven Isakoff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/03e0ba082d824a39b3cb3ba0fcab7adb
Autor:
Jeff DeFalco, Gilson Baia, Judevin Lugar-Supagay, Ish Dhawan, Dai-Chen Wu, Carl Millward, Jonathan Benjamin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/9a59eb33c2834ec5915b11e07f6a0c7d
Autor:
Alexander Scholz, Jeff DeFalco, Yvonne Leung, Iraz T. Aydin, Cathrin J. Czupalla, Wei Cao, Daniel Santos, Nikhil Vad, Shaun M. Lippow, Gilson Baia, Michael Harbell, Judevin Sapugay, Danhui Zhang, Dai-Chen Wu, Erin Wechsler, Anne Z. Ye, Jenny W. Wu, Xiao Peng, John Vivian, Hargita Kaplan, Rodney Collins, Ngan Nguyen, Mark Whidden, Dongkyoon Kim, Carl Millward, Jonathan Benjamin, Norman M. Greenberg, Tito A. Serafini, Daniel E. Emerling, Lawrence Steinman, William H. Robinson, Amy Manning-Bog
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Immunotherapy approaches focusing on T cells have provided breakthroughs in treating solid tumors. However, there remains an opportunity to drive anticancer immune responses via other cell types, particularly myeloid cells. ATRC-101 was identified vi
Autor:
Kimberly Walter, John D. Powderly, Andrew Wrong, Steven J. Isakoff, Jeremy Clifton Jones, Susanna Varkey Ulahannan, Ngan Nguyen, Yan Xing, Lixia Wang, Mark Whidden, Paul Del Castillo, Deborah Doroshow, S. John Weroha, Frances Valdes-Albini, Carl Millward, Jonathan Benjamin, Tanios Bekaii-Saab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundATRC-101 is an engineered version of an immunoglobulin G1 antibody that was discovered in a patient with non-small cell lung cancer (NSCLC) experiencing stable disease while being treated with anti–programmed death-1 therapy. ATRC-101 tar
Autor:
John Vivian, Kimberly Walter, Elliott Drabek, Nicole Haaser, Maren K. Levin, Esther San Roman Rodriguez, Kendra Peck, Ngan Nguyen, Carl Millward, Jonathan Benjamin, William H. Robinson, Joyce A. O'Shaughnessy
Publikováno v:
Cancer Research. 82:P2-01
Background: Human epidermal growth factor receptor 2 (HER2) positivity in breast cancer portends an aggressive tumor behavior and poor prognosis and is associated with a positive response to trastuzumab treatment. Prior immunohistochemistry and RNA s
Autor:
Iraz T Aydin, Alexander Scholz, Ish Dhawan, Yanhong Zhu, Zane Rogers, Daniel Emerling, Jeff DeFalco, Jonathan Benjamin, Norman M. Greenberg, Danhui Zhang, Shaun M. Lippow, Nicholas Higgins, Anna Sedello, Carl Millward, Amy Manning-Bog, Yvonne W. Leung, William H. Robinson, Tito Serafini
Publikováno v:
Cancer Research. 81:CT203-CT203
Background: ATRC-101 is a fully human, engineered IgG1 version of an antibody discovered through a target-agnostic process designed to identify patient-derived, tumor-targeting antibodies. The parental antibody of ATRC-101 was discovered from a patie
Autor:
Amy Manning-Bog, Yvonne W. Leung, Yanhong Zhu, Nicholas Higgins, Daniel Emerling, Tito Serafini, Jeff DeFalco, Jonathan Benjamin, Alexander Scholz, Ish Dhawan, Anna Sedello, Iraz T Aydin, Norman M. Greenberg, Zane Rogers, Shaun M. Lippow, Danhui Zhang, William H. Robinson, Carl Millward
Publikováno v:
Journal of Clinical Oncology. 38:TPS3168-TPS3168
TPS3168 Background: ATRC-101 is a fully human, engineered IgG1 version of an antibody discovered through a a target-agnostic screen to identify patient-derived antibodies that bind selectively to public tumor antigens. The parental antibody was ident
Autor:
C Yoshizawa, Joseph M. Anderson, S Shak, V. Tan, FL Baehner, Eric P. Winer, Carl Millward, Drew Watson
Publikováno v:
Cancer Research. 70:P3-10
Background: Classic lobular carcinoma is characterized by a distinctive morphology, loss of E-cadherin commonly due to mutation or deletion of CDH1 on chromosome 16q, and a variable clinical course (Pestalozzi J Clin Oncol. 2008 26:3006). Variants (p
Autor:
Nadine S I, Aguilera, Jian, Chen, Karen E, Bijwaard, Alison E, Director-Myska, Carol L, Barekman, Carl, Millward, Jack, Lichy, Susan L, Abbondanzo
Publikováno v:
Archives of Pathology & Laboratory Medicine. 130:1772-1779
Context.—Reed-Sternberg cells in classic Hodgkin lymphoma are enigmatic and difficult to study because they are so sparse. Tissue microdissection allows for the isolation of single Reed-Sternberg cells. Isolated Reed-Sternberg cells show clonal imm